Selected article for: "acid amplification and acute respiratory tract infection"

Author: Peters, Rebecca Marie; Schnee, Sarah Valerie; Tabatabai, Julia; Schnitzler, Paul; Pfeil, Johannes
Title: Evaluation of Alere i RSV for Rapid Detection of Respiratory Syncytial Virus in Children Hospitalized with Acute Respiratory Tract Infection
  • Document date: 2017_3_24
  • ID: 1v56m2vq_2
    Snippet: A major limitation of point-of-care RSV testing is the low sensitivity of currently available rapid antigen detection tests (RADT). In general, RADT sensitivity is strongly dependent on high viral load of respiratory specimens and therefore performs best in young infants with classical symptoms of RSV bronchiolitis. A pooled RADT sensitivity of 80% (95% confidence interval [CI], 76% to 83%) was reported for pediatric patients (4) . In our screeni.....
    Document: A major limitation of point-of-care RSV testing is the low sensitivity of currently available rapid antigen detection tests (RADT). In general, RADT sensitivity is strongly dependent on high viral load of respiratory specimens and therefore performs best in young infants with classical symptoms of RSV bronchiolitis. A pooled RADT sensitivity of 80% (95% confidence interval [CI], 76% to 83%) was reported for pediatric patients (4) . In our screening population of children Ͻ18 years of age who were hospitalized with any symptom of respiratory tract infection, we observed RADT sensitivity of 63% (95% CI, 55% to 72%) compared to reverse transcription-PCR (RT-PCR) (5), while in adults, sensitivities of different RADT were Ͻ25% (6). As an alternative to RADT, rapid nucleic acid amplification assays have been developed to facilitate early recognition of RSV infection. These assays provide high sensitivities but require a testing time of at least 1 h (7, 8) . The Alere i system is a rapid, automated in vitro diagnostic test which utilizes a nicking enzyme amplification reaction. The platform technology was previously developed for the detection of influenza virus (Alere i influenza) and provides test results in less than 15 min. The test is optimized for point-of-care settings and does not require specific training or experience in laboratory techniques. A number of studies have evaluated this rapid influenza test in comparison to both viral culture and RT-PCR, reporting sensitivities between 45 and 100% (9) (10) (11) (12) (13) (14) (15) . Recently, the platform has been extended with test cartridges for the detection of streptococcus A (Alere i Strep A) and RSV (Alere i RSV). Both assays are being introduced into routine clinical care. No data have been published regarding the sensitivity and specificity of the novel Alere i RSV test. The objective of our study was to evaluate the performance of the Alere i RSV test for rapid detection of RSV in children hospitalized with acute respiratory tract infection.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory tract infection and alere rsv: 1, 2, 3
    • acute respiratory tract infection and antigen detection: 1, 2, 3
    • acute respiratory tract infection and antigen detection test: 1
    • acute respiratory tract infection and care point: 1, 2, 3, 4, 5
    • acute respiratory tract infection and care point setting: 1
    • acute respiratory tract infection and CI confidence interval: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory tract infection and clinical care: 1, 2, 3, 4, 5
    • Alere influenza and care point: 1, 2, 3
    • Alere influenza and care point setting: 1
    • Alere performance and care point: 1, 2, 3, 4
    • Alere performance and care point setting: 1
    • Alere performance and clinical care: 1
    • alere rsv and care point: 1, 2, 3, 4, 5
    • alere rsv and care point setting: 1
    • alere rsv and clinical care: 1
    • antigen detection and care point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antigen detection and care point rsv testing: 1
    • antigen detection and CI confidence interval: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • antigen detection and clinical care: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12